Cited by 308

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol

Koo, H.·2003·Journal of Antimicrobial Chemotherapy

Abstract

Objectives Apigenin is a potent inhibitor of glucosyltransferases and tt-farnesol affects the membrane integrity of Streptococcus mutans. We investigated the influence of apigenin and tt-farnesol, alone and in combination, on the accumulation, polysaccharide composition and viability of S. mutans UA159 biofilms. Methods Initially, biofilms were grown for 54 h; then, the early-formed biofilms were treated for 1 min twice daily with one of the following: (i). 1.33 mM tt-farnesol; (ii). 1.33 mM apigenin; (iii). apigenin + tt-farnesol (1.33 mM each); (iv). vehicle control (20% ethanol with 0.75% dimethyl sulphoxide); (v). 0.12% chlorhexidine (1.33 mM); or (vi). physiological saline (145 mM NaCl). The procedure was repeated at biofilm ages of 78 and 102 h, and biofilms were harvested at 126 h. The dry weight, protein concentration, number of cfu, and polysaccharide composition per biofilm were determined. Results The dry weights of the biofilms treated with the test agents were significantly less (30-50%) than those treated with vehicle control (P Conclusions Apigenin and tt-farnesol affected the accumulation and polysaccharide content of S. mutans biofilms without major impact on the bacterial viability.

Overview

Integrity signals

Registry

Crossref · 10.1093/jac/dkg449

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many biofilm models still use surrogates of dental substrates instead of enamel or dentine.

    “Among several biofilms models [28–33], many still use surrogates of dental substrates [29, 31, 32] instead the use of enamel or dentine, which our research group has used [28, 33–37].”
  • We improved a S. mutans biofilm model, which was validated to evaluate the effect of antibacterial substances on biofilm formation and enamel demineralization, named cariogenic biofilm model given the cariogenic properties of this bacterium.

    “For this purpose, we improved a S. mutans biofilm model [32], which was validated to evaluate the effect of antibacterial substances on biofilm formation [28] and enamel demineralization [37], named cariogenic biofilm model [36] given the cariogenic properties of this bacterium.”

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Koo, H.
Venue
Journal of Antimicrobial Chemotherapy
Published
2003-09-30
Volume
52
Issue
5
Pages
782-789
ISSN
1460-2091
Cited by
308
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review